Pharma Journalist - Page 45 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Mangoceuticals Launches Direct GLP-1 Access Programs for Affordable Weight-Loss Care

MeiraGTx Partners with Eli Lilly in $475M Gene Therapy Deal to Restore Vision in Children

Insilico Medicine Expands AI Drug Discovery Partnership with Eli Lilly in $100M Collaboration

SanegeneBio Partners with Eli Lilly in $1.2 Billion RNAi Metabolic Disease Collaboration

Harbour BioMed, Evinova Partner to Advance AI-Driven Biologic Drug Development

Novartis Opens New Radioligand Therapy Manufacturing Facility in California to Boost U.S. Cancer Treatment Capacity

Lyell Immunopharma Boosts Solid Tumor Pipeline with Acquisition of Promising CAR T Therapy for Colorectal Cancer

Pelthos Acquires U.S. Rights to Xepi Cream, Secures $18M Financing to Relaunch Product

Alvotech and Advanz Pharma Secure UK Approval for Gobivaz, a Biosimilar to Simponi

Abzena and Mabqi Form Strategic Partnership to Accelerate Antibody Drug Development